(Q48312680)

10 February 2018

reason for preferred rank

title

Intraventricular infusion of antagonists of IL-1 and TNFα attenuates neurodegeneration induced by the infection of Trypanosoma brucei (English)

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

1 January 2024

Intraventricular infusion of antagonists of IL-1 and TNF alpha attenuates neurodegeneration induced by the infection of Trypanosoma brucei (English)

1 reference

PubMed ID

12742658

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742658

1 January 2024

0 references

0 references

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

1 January 2024

1 reference

Ning Quan

1

1 reference

10 February 2018

Lingli He

2

1 reference

10 February 2018

Wenmin Lai

3

1 reference

10 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

PubMed ID

12742658

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12742658

1 January 2024

publication date

1 May 2003

1 reference

10 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S016557280300122X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

https://api.elsevier.com/content/article/PII:S016557280300122X?httpAccept=text/plain

1 January 2024

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

Journal of Neuroimmunology

1 January 2024

published in

1 reference

10 February 2018

volume

138

1 reference

10 February 2018

issue

1-2

1 reference

10 February 2018

page(s)

92-98

1 reference

10 February 2018

An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Rolipram reduces excitotoxic neuronal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Central mediation of the effects of interleukin-1 on social exploration and body weight in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Induction of endothelial nitric-oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Alterations of serum lipid, lipoprotein and inflammatory cytokine profiles of rabbits infected with Trypanosoma brucei brucei

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Pentoxifylline suppression of TNF-alpha mediated axonal degeneration in the rabbit optic nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Induction of inhibitory factor kappaBalpha mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Chronic sodium salicylate treatment exacerbates brain neurodegeneration in rats infected with Trypanosoma brucei

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Application of silver degeneration stains for neurotoxicity testing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900122-X

7 January 2021

An IL-1 receptor and an IL-1 receptor antagonist attenuate muramyl dipeptide- and IL-1-induced sleep and fever

8

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

Immune depression in Trypanosoma brucei brucei infected mice. Sequential histological and immunological findings

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

Connecting cytokines and brain: a review of current issues

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1016/S0165-5728(03)00122-X

1 January 2024

Identifiers

1 reference

10 February 2018

PubMed ID

12742658

1 reference

10 February 2018